What is the recommended treatment for neurosyphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Neurosyphilis

The recommended treatment for neurosyphilis is aqueous crystalline penicillin G 18-24 million units per day, administered as 3-4 million units IV every 4 hours or by continuous infusion, for 10-14 days. 1, 2, 3

Primary Treatment Regimen

  • Aqueous crystalline penicillin G remains the gold standard, delivering 18-24 million units daily via IV route for 10-14 days 1, 2
  • The medication can be administered either as 3-4 million units IV every 4 hours or as a continuous infusion 1, 3
  • This regimen ensures adequate CSF penetration with penicillin concentrations continuously above the minimal treponemicidal level 4

Alternative Regimen (When IV Access is Problematic)

If compliance can be ensured and IV access is difficult:

  • Procaine penicillin 2.4 million units IM once daily 1, 2
  • PLUS Probenecid 500 mg orally four times daily 1, 2
  • Both medications given for 10-14 days 1
  • Important caveat: HIV-infected patients allergic to sulfa-containing medications should NOT receive probenecid due to potential allergic reactions 1

Extended Therapy Consideration

Because the neurosyphilis treatment duration (10-14 days) is shorter than late syphilis treatment, benzathine penicillin 2.4 million units IM once weekly for up to 3 weeks can be added after completing the neurosyphilis regimen to provide comparable total treatment duration. 1, 2

Management of Penicillin Allergy

This is a critical clinical scenario requiring careful handling:

  • Penicillin desensitization is the strongly preferred approach for penicillin-allergic patients, as penicillin remains the only proven effective treatment 1, 5
  • Ceftriaxone 2 g daily (IM or IV) for 10-14 days may be used as an alternative, but with significant caveats 1, 2
  • Major limitation: Cross-reactivity between ceftriaxone and penicillin exists, potentially causing allergic reactions 1, 2
  • Skin testing to confirm penicillin allergy should be performed when concern exists about ceftriaxone safety 1
  • Other alternative regimens have not been adequately evaluated and should be avoided 1

Special Populations

HIV-Infected Patients

  • Use the same treatment regimen as HIV-negative patients (aqueous crystalline penicillin G 18-24 million units daily for 10-14 days) 1, 5
  • Critical warning: HIV-infected patients with early syphilis have higher risk of neurological complications and higher rates of serological treatment failure 1, 2, 6
  • Prior treatment with benzathine penicillin G may fail in HIV-infected patients, leading to neurosyphilis development 7
  • High-dose IV penicillin is not consistently effective in all HIV-infected patients with neurosyphilis 7
  • Closer follow-up is essential to detect treatment failures or disease progression 5

Ocular Syphilis

  • All patients with syphilitic eye disease (uveitis, neuroretinitis, optic neuritis) must be treated with the full neurosyphilis regimen, not early syphilis treatment 1, 2
  • Management should occur in collaboration with an ophthalmologist 1, 5
  • CSF examination is mandatory for all patients with ocular manifestations to identify abnormalities requiring follow-up 1

Pregnant Patients

  • Pregnant patients allergic to penicillin must be desensitized and treated with penicillin - no alternatives are acceptable 1

Mandatory Concurrent Testing

  • All patients with neurosyphilis must be tested for HIV 1, 2, 6

Follow-Up Protocol

CSF Monitoring

  • If CSF pleocytosis was present initially, repeat CSF examination every 6 months until cell count normalizes 1, 2, 6
  • The CSF leukocyte count is the most sensitive measure of treatment effectiveness 1, 2, 6
  • CSF-VDRL and protein changes occur more slowly than cell count changes and persistent abnormalities may be less clinically significant 1

Criteria for Retreatment

Retreatment should be considered if: 1, 2, 6

  • Cell count has not decreased after 6 months
  • CSF cell count or protein is not normal after 2 years

Serologic Monitoring

  • Perform quantitative nontreponemal tests at 3,6,9,12, and 24 months after therapy 1, 5
  • Expect at least a fourfold decline in serum nontreponemal titers 1
  • If titers do not decline fourfold, repeat CSF examination and consider retreatment 1

Common Pitfalls to Avoid

  1. Do not treat ocular syphilis as early syphilis - it requires the full neurosyphilis regimen regardless of CSF findings 1
  2. Do not use alternative antibiotics without penicillin desensitization in penicillin-allergic patients - the evidence for alternatives is insufficient 1, 5
  3. Do not assume benzathine penicillin adequately treats neurosyphilis - it does not achieve adequate CSF levels 7
  4. Do not give probenecid to sulfa-allergic patients when using the procaine penicillin alternative regimen 1
  5. Do not skip HIV testing - all neurosyphilis patients require HIV screening 1, 2, 6

Evidence Quality Note

While CDC guidelines consistently recommend aqueous crystalline penicillin G across multiple iterations (2002,2010), the actual research evidence supporting this recommendation is limited. A 2019 Cochrane review found only one small trial (36 participants) comparing ceftriaxone to penicillin G, with very low-quality evidence and inconclusive results 8. Despite this limitation, penicillin G remains the standard of care based on decades of clinical experience and the absence of proven superior alternatives.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tratamiento de Neurosífilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento de la Neurosífilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Retratamiento de Neurosífilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic therapy for adults with neurosyphilis.

The Cochrane database of systematic reviews, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.